Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases
Ché Serguera(Centre National de la Recherche Scientifique), Kumaran Deiva(Sorbonne Université)
Cited by 20
Related Papers
Myelin-oligodendrocyte glycoprotein antibody-associated disease
|The Lancet Neurology|2021|518
Treatment of MOG antibody associated disorders: results of an international survey.
|Research Padua Archive (University of Padua)|2020|139
Treatment and outcome of children and adolescents with N-methyl-d-aspartate receptor encephalitis
|Journal of Neurology|2015|120
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II
|Multiple Sclerosis Journal|2022|103